Expert Interview
Reviewing the potential of AAV-GAD, a gene therapy from MeiraGTx for the treatment of Parkinson's Disease
Ticker(s): MGTXInstitution: University of Miami
- Assistant Professor of Clinical Neurology in the Movement Disorders Division at the University of Miami.
- Currently manages 80 patients with Alzheimer's disease.
- Research interests include Parkinson' disease and a broad interest in neurodegenerative disorders and movement disorders in particular.
How many patients do you manage with Parkinson's?
Added By: ben_adminWhat are your thoughts on the potential of AAV-GAD?
Added By: ben_adminDescribe your background and current practice setting. How many patients with PD do you manage?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
